Pfizer-Allergan deal may be imperilled by US inversion rules

The US has taken steps to limit the tax-cutting power of corporate inversions

5th April, 2016
New US rules may put Pfizer's planned merger with Allergan in jeopardy

The Treasury Department said the rules would limit companies’ ability to participate in inversion transactions if they’ve already done them within the past 36 months. Allergan has been involved in several mergers in that time frame. In a corporate inversion, a US company merges with a smaller foreign firm and then transfers the new company’s tax address offshore.

Pfizer and Allergan were reviewing the Treasury Department’s announcement on Monday night,...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Aidan Regan: A tale of one city and a two-tier economy operating beneath it

Bannon could embrace ‘martyr’ role as he defies House subpoena

US Marion McKeone 1 day ago

Virginia governor race a straw in the wind for US midterms

US Marion McKeone 1 day ago

Massive expansion in size of state will continue – but how will this money-printing experiment end?